title: Does model for end-stage liver disease (MELD) require modification?
abstract: Model for End-stage Liver Disease (MELD) measures serum bilirubin (mg/dL), serum albumin (g/dL), International Normalised Ratio (INR) for prothrombin time. MELD score accurately predicts survival in 3 months for cirrhotic patients on the waiting list of liver transplantation. In about 15% of patients, it does not accurately predict survival and hence MELD-Na is recommended. MELD score is a poor predictor of survival after liver transplantation. Downgrading of MELD score for age of recipient and chance of recurrence of the disease is recommended to accurately predict survival after liver transplantation.
authors.affiliation: Jaslok Hospital and Research Centre, Dr G Deshmukh Marg, Mumbai 400 026.
authors.forename: H G
authors.initials: HG
authors.lastname: Desai
mesh_terms: D001663:Bilirubin / Q000097:blood; D058625:End Stage Liver Disease / Q000401:mortality / Q000601:surgery*; D006801:Humans; D019934:International Normalized Ratio; D016031:Liver Transplantation; D008962:Models, Theoretical; D011237:Predictive Value of Tests; D011379:Prognosis; D011517:Prothrombin Time; D012709:Serum Albumin / Q000378:metabolism; D012720:Severity of Illness Index; D016019:Survival Analysis; D013997:Time Factors; D014850:Waiting Lists
chemical_list: D012709:Serum Albumin; D001663:Bilirubin